Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Why Is Verici Dx PLC LSE:VRCI in Focus Amid investor focus on its transplant diagnostics tests and the pace of commercial adoption?

Verici Dx PLC — LSE:VRCI is attracting investor attention amidinvestor focus on its transplant diagnostics tests and the pace of commercial adoption.

Ishan Mudgal | 21 August 2026

Why Is Aptamer Group PLC LSE:APTA in Focus Amid investor focus on its aptamer binder platform and its pharmaceutical partnerships?

Aptamer Group PLC — LSE:APTA is attracting investor attention amidinvestor focus on its aptamer binder platform and its pharmaceutical partnerships.

Ishan Mudgal | 21 August 2026

Why Is Futura Medical PLC LSE:FUM in Focus Amid investor focus on the commercial rollout of its topical treatment and its distribution agreements?

Futura Medical PLC — LSE:FUM is attracting investor attention amidinvestor focus on the commercial rollout of its topical treatment and its distribution agreements.

Ishan Mudgal | 21 August 2026

Why Is Integrated Diagnostics Holdings PLC LSE:IDHC in Focus Amid investor focus on its Middle East and African diagnostics operations and Egyptian currency movements?

Integrated Diagnostics Holdings PLC — LSE:IDHC is attracting investor attention amidinvestor focus on its Middle East and African diagnostics operations and Egyptian currency movements.

Ishan Mudgal | 21 August 2026

Why Is Nuformix PLC LSE:NFX in Focus Amid investor focus on its drug repurposing programmes and its cocrystal platform?

Nuformix PLC — LSE:NFX is attracting investor attention amidinvestor focus on its drug repurposing programmes and its cocrystal platform.

Ishan Mudgal | 21 August 2026

MedPal AI Surges as Investors Chase Another Emerging AI Healthcare Story

MedPal AI has gone from a pre-revenue AIM newcomer to an £8.6m revenue run-rate online pharmacy in under a year — but a wafer-thin cash balance and relentless share issuance keep the risks in plain view.

Ankur Sharma | 21 August 2026

Abingdon Health Moves Higher — Could Diagnostics Momentum Be Returning?

The York-based lateral-flow specialist has spent the past year rebuilding itself around contract development and manufacturing. After a trading update pointing to 31% revenue growth and a maiden move into second-half profitability, investors are weighing whether the momentum can carry into a bigger FY27.

Ankur Sharma | 21 August 2026

Kromek Shares Rise as Investors Revisit the Detection-Technology Specialist

Shares in Kromek Group (LSE:KMK) edged higher, adding close to 5% in a session that left the AIM-quoted radiation and bio-detection specialist back among the day's more actively watched small caps. For a company whose stock trades in single-digit pence and whose order flow …

Ankur Sharma | 21 August 2026

Feedback Shares Surge as Traders Pile Back Into the Healthcare-Tech Small Cap

Feedback plc, the AIM-listed maker of the Bleepa clinical-communications platform, jumped more than 11% in a single session, a reminder of how quickly sentiment can turn in a micro-cap whose fortunes are tied almost entirely to NHS spending decisions.

Ankur Sharma | 21 August 2026

Shield Therapeutics Breaks Higher — Investors Put the Iron-Deficiency Specialist Back in Focus

Shield Therapeutics' shares snapped higher as investors took a second look at half-year figures showing US prescriptions climbing and losses shrinking towards the company's long-promised profitability target. For aBusinessthat has leaned repeatedly on its largestShareholderfor cash, the question is whether commercial momentum can finally …

Ankur Sharma | 21 August 2026
Support

Hi! How can we help you today?

Loading…